300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Cryptocurrency
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Hospitality
Biotechnology
Consumer
Sports
Legal
eSports
Software
Renewable Energy
Construction
Crowdfunding
Venture Capital
Theatre
Medical
Fashion
Recruiting
Social
Web3
Beauty
Cannabis
Infrastructure
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Music
Wine and Spirits
Food and Beverage
Publishing
Manufacturing
Art
Digital Media
FinTech
Finance
Financial Services
Real Estate
Social Media
Franchise
Mobile Advertising
Sporting Goods
Non Profit
Internet
Android
Sustainability
Hardware
Enterprise
Biotech
Impact
Proptech
Community
Media (Entertainment)
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Greece
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Czech Republic
China
Armenia
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
NBGI Ventures, VC Fund

NBGI Ventures

VC Fund

London, United Kingdom

NBGI Ventures is a venture capital fund focused on investing in seed, early, and middle stage medical technology companies. It was established in 2001 and is headquartered in London, United Kingdom.

Total investments:
8
Last investment:
Lead investor:
13%

Last updated:

Industries NBGI Ventures invests in

Health CareBiotechnologyMedical DeviceMedical3D Technology

Stages NBGI Ventures invests in

Series BSeries AFunding RoundPrivate Equity

Countries NBGI Ventures invests in

FranceDenmarkUnited StatesUnited Kingdom

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Health Care 3 (38%)
  • Biotechnology 3 (38%)
  • Medical Device 3 (38%)
  • Medical 1 (13%)
  • 3D Technology 1 (13%)
See all 9 industries →

Stage

  • Series B 3 (38%)
  • Series A 2 (25%)
  • Funding Round 2 (25%)
  • Private Equity 1 (13%)

Country

  • France 2 (25%)
  • Denmark 1 (13%)
  • United States 1 (13%)
  • United Kingdom 1 (13%)

Team

NameTitleInvestmentsLinksEmail
Yoann Malys
Yoann Malys Team member
Team member Total investments: 1
Find email
James Huckle
James Huckle Director
Director Total investments: 0 Find email
Mark Holland
Mark Holland Head of IT
Head of IT Total investments: 0 Find email
Mia Lauranti
Mia Lauranti Team member
Team member Total investments: 0 Find email
Omiros Millas
Omiros Millas Director
Director Total investments: 0 Find email
See all 9 team members →

Investments

CompanyDescriptionRoundLinks
Quanta Quanta
Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system.SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flowrates of traditional in-centre machines.SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians. $35.4M / Series B / Nov 03, 2014
SuperSonic Imagine SuperSonic Imagine
SuperSonic Imagine SA develops and manufactures ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company provides Aixplorer, an ultrasound system for breast lesion imaging; and ShearWave, an ultrasound technology platform for quantitative elastography. It offers its products through its offices and a networkof distributors in France, Belgium, Austria, Croatia, Poland, the Czech Republic, Singapore, Taiwan, Thailand, Malaysia, Hong Kong, Lebanon, Germany, the United Kingdom, and the United States. SuperSonic Imagine SA was founded in 2005 and is based in Aix-en-Provence, France with additional offices in Germany, the United States, and the United Kingdom. $30.7M / Private Equity / Apr 02, 2013
Reverse Medical Reverse Medical
Reverse Medical is a commercial-stage medical device company focused on revascularizing patients experiencing Acute Ischemic Stroke. $14M / Series B / Apr 07, 2010
Quanta Quanta
Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system.SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flowrates of traditional in-centre machines.SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians. $14.3M / Series A / Nov 01, 2009
SuperSonic Imagine SuperSonic Imagine
SuperSonic Imagine SA develops and manufactures ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company provides Aixplorer, an ultrasound system for breast lesion imaging; and ShearWave, an ultrasound technology platform for quantitative elastography. It offers its products through its offices and a networkof distributors in France, Belgium, Austria, Croatia, Poland, the Czech Republic, Singapore, Taiwan, Thailand, Malaysia, Hong Kong, Lebanon, Germany, the United Kingdom, and the United States. SuperSonic Imagine SA was founded in 2005 and is based in Aix-en-Provence, France with additional offices in Germany, the United States, and the United Kingdom. $21.9M / Series B / Oct 23, 2008
EOS Imaging EOS Imaging
EOS imaging is a medical company revolutionizing the treatment continuum for the most common osteoarticular conditions (hip, knee and spine) and associated orthopedic surgeries.Its EOS® 2D/3D imaging system is specifically adapted to the needs of orthopedic surgeons and radiologists. This personalized imaging tool gives a precise 3D imageof the patient's skeleton in the upright position that can be used to inform all aspects of care. The Company has obtained authorization to market the system in 48 countries. The Company is based in Paris, with a subsidiary in the United States in Cambridge, Massachusetts, as well as offices in Montreal (Canada) and Germany. $18M / Nov 27, 2007
Upfront Chromatography Upfront Chromatography
Upfront Chromatography is a Denmark-based biotech company with significant expertise and regulatory experience in the development of customised industrial processes. Upfront develops and manufactures innovative products and technologies for extraction and recovery of biotherapeutics, functional biomolecules, macromolecular complexes, and evenliving cells, directly from bioreactors and industrial side-streams. $9.2M / Sep 24, 2007
SuperSonic Imagine SuperSonic Imagine
SuperSonic Imagine SA develops and manufactures ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company provides Aixplorer, an ultrasound system for breast lesion imaging; and ShearWave, an ultrasound technology platform for quantitative elastography. It offers its products through its offices and a networkof distributors in France, Belgium, Austria, Croatia, Poland, the Czech Republic, Singapore, Taiwan, Thailand, Malaysia, Hong Kong, Lebanon, Germany, the United Kingdom, and the United States. SuperSonic Imagine SA was founded in 2005 and is based in Aix-en-Provence, France with additional offices in Germany, the United States, and the United Kingdom. $11M / Series A / Mar 01, 2006

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Cryptocurrency
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Hospitality
Biotechnology
Consumer
Sports
Legal
eSports
Software
Renewable Energy
Construction
Crowdfunding
Venture Capital
Theatre
Medical
Fashion
Recruiting
Social
Web3
Beauty
Cannabis
Infrastructure
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Music
Wine and Spirits
Food and Beverage
Publishing
Manufacturing
Art
Digital Media
FinTech
Finance
Financial Services
Real Estate
Social Media
Franchise
Mobile Advertising
Sporting Goods
Non Profit
Internet
Android
Sustainability
Hardware
Enterprise
Biotech
Impact
Proptech
Community
Media (Entertainment)
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Greece
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Czech Republic
China
Armenia
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does NBGI Ventures invest in?

NBGI Ventures invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series B and Series A stage. Most of the 8 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact NBGI Ventures?

Public channels for NBGI Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at NBGI Ventures?

The team at NBGI Ventures includes Yoann Malys (Team member), James Huckle (Director) and Mark Holland (Head of IT), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
NBGI Ventures NBGI Ventures Find emails